Last reviewed · How we verify
NCT04226144
Breath Stacking Technique Associated With Expiratory Muscle Training in Amyotrophic Lateral Sclerosis Patients
NA trial testing Breath Stacking Group in Amyotrophic Lateral Sclerosis in 50 participants. Terminated before completion.
31 August 2021
Quick facts
| Lead sponsor | Escola Superior de Ciencias da Saude |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 6 January 2020 |
| Primary completion | 31 August 2021 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Breath Stacking Group
- Breath stacking and EMT
Conditions studied
- Amyotrophic Lateral Sclerosis — all drugs for Amyotrophic Lateral Sclerosis →
- Neuromuscular Diseases — all drugs for Neuromuscular Diseases →
Sponsor
Escola Superior de Ciencias da Saude
Who can join
18 and older, any sex, with Amyotrophic Lateral Sclerosis or Neuromuscular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
it will be conducted a randomized parallel controlled trial with patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) to compare two techniques to lung recruitment and cough augmentation, to assess their effects on pulmonary function, global functionally, swallowing and ability to speech in these population.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A pilot study of the breath stacking technique associated with respiratory muscle endurance training in patients with amyotrophic lateral sclerosis: videofluoroscopic findings in the upper airway.
Dorça A, Sarmet M, Rocha EMSS, Marra MB, et al · · 2021 · cited 4× · PMID 34196381 · DOI 10.5603/arm.a2021.0045 -
Comparison between breath stacking technique associated with expiratory muscle training and breath stacking technique in amyotrophic lateral sclerosis patients: Protocol for randomized single blind trial.
Dorça A, Alcântara LA, Diniz DS, Sarmet M, et al · · 2020 · cited 4× · PMID 33005816 · DOI 10.1016/j.conctc.2020.100647
Verify or expand the search:
- PubMed search for NCT04226144
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amyotrophic Lateral Sclerosis
Currently open trials in the same condition.
- NCT07502677 — Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Scle · recruiting
- NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
- NCT07204977 — Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) · Phase 1 · active not recruiting
- NCT07290062 — A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants · Phase 1 · recruiting
- NCT07259980 — A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD- · recruiting
Other Escola Superior de Ciencias da Saude trials
Trials by the same sponsor.
- NCT06712979 — Addiction of Lung Volume Recruitment Technique in Lee Silverman Protocol for Voice Professionals · NA · not yet recruiting
- NCT04595097 — Inspiratory Muscle Training in COVID-19 Patients · NA · completed
- NCT04382378 — Effects of NMES in Critically Ill Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04226144 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Escola Superior de Ciencias da Saude
- Last refreshed: 4 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04226144.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing